Pine Labs delivered a strong market debut, listing at a 9.5% premium and rallying further to give IPO investors gains of nearly 30% from the IPO price. Brokerages remain positive on the company’s long-term prospects but advise allotted investors to hold.
Tata Sons boardroom battle intensifies but Tata Group stocks remain unbothered. Should you buy?
Tata Sons has rejected Noel Tata’s objections to N Chandrasekaran’s reappointment, saying the board’s decision was valid and made in accordance with the company’s Articles